Fiscal 27 growth depends on back-half ClearEyes supply recovery while acquisitions add longer-term upside.
| Quarter | Q4 FY26 |
|---|---|
| Call date | 2026-05-15 |
| Length | 62 minutes |
| EPS | $1.23 |
| EPS consensus | $1.39 |
| Revenue | $281.6M |
| Revenue consensus | $293.6M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
Other quarters: Q1 FY27 · Q3 FY26
All PBH earnings · Back to PBH overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.